Simpler Grants.gov #PAR-25-296

NIH CTSA Program: Collaborative and Innovative Acceleration Award (Research Grant Opportunity)

The National Institutes of Health (NIH) is inviting applications for the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (CCIA). - Government Buyer: - National Institutes of Health (NIH) - National Center for Advancing Translational Sciences (NCATS) - Additional involvement from NIH offices: Office of Research on Women's Health, Allergy and Infectious Diseases Research, Human Genome Research, Arthritis, Musculoskeletal and Skin Diseases Research, Oral Diseases and Disorders Research, Child Health and Human Development Extramural Research, Minority Health and Health Disparities Research, and Biomedical Research and Research Training - Products/Services Requested: - No specific commercial products or services are being procured - The opportunity funds investigator-initiated research projects to develop, demonstrate, and disseminate innovative approaches, technologies, resources, or models that accelerate translational research - Unique/Notable Requirements: - Focus on accelerating translational research and increasing impact across diseases - Open to public and state institutions of higher education - Minimum funding amount of $650,000 - No cost sharing or matching required - Cooperative agreement mechanism (UG3/UH3, clinical trial optional) - OEMs and Vendors: - No OEMs or commercial vendors are specified, as this is a research grant opportunity, not a product or service procurement

Description

The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This funding opportunity invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform translational science, and bring treatments to people more quickly. Eligible applicants include public and state institutions of higher education, with additional eligibility criteria detailed in the NOFO. The award is a cooperative agreement with a minimum funding amount of $650,000 and no cost sharing requirement.

View original listing